Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.

Gafita A, Heck M, Rauscher I, Tauber R, Cala L, Franz C, D'Alessandria C, Retz M, Weber WA, Eiber M.

J Nucl Med. 2020 Feb 28. pii: jnumed.119.240242. doi: 10.2967/jnumed.119.240242. [Epub ahead of print]

PMID:
32111687
2.

Enhanced specificity due to method specific limits for relative ion intensities in a high-performance liquid chromatography - tandem mass spectrometry method for iohexol in human serum.

Schweinsberg V, Eckelt S, Schulz AM, Arlt M, Schumann M, van der Giet M, Tauber R, Binscheck-Domaß T, Kießling P.

Clin Chem Lab Med. 2020 Apr 28;58(5):709-718. doi: 10.1515/cclm-2019-1001.

PMID:
32069224
3.

Platelet-derived growth factor receptor β activation and regulation in murine myelofibrosis.

Kramer F, Dernedde J, Mezheyeuski A, Tauber R, Micke P, Kappert K.

Haematologica. 2019 Oct 31. pii: haematol.2019.226332. doi: 10.3324/haematol.2019.226332. [Epub ahead of print]

4.

Underfilling of vacuum blood collection tubes leads to increased lactate dehydrogenase activity in serum and heparin plasma samples.

Neuwinger N, Meyer Zum Büschenfelde D, Tauber R, Kappert K.

Clin Chem Lab Med. 2020 Jan 28;58(2):213-221. doi: 10.1515/cclm-2019-0616.

PMID:
31665108
5.

Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer.

Gafita A, Wang H, Tauber R, D'Alessandria C, Weber WA, Eiber M.

Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2212-2213. doi: 10.1007/s00259-019-04410-8. Epub 2019 Jul 4. No abstract available.

PMID:
31273434
6.

Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays.

Schwamborn K, Ammann JU, Knüchel R, Hartmann A, Baretton G, Lasitschka F, Schirmacher P, Braunschweig T, Tauber R, Erlmeier F, Hieke-Schulz S, Weichert W.

Virchows Arch. 2019 Nov;475(5):599-608. doi: 10.1007/s00428-019-02610-z. Epub 2019 Jul 2.

7.

Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial.

Schönenberger E, Martus P, Bosserdt M, Zimmermann E, Tauber R, Laule M, Dewey M.

Radiology. 2019 Sep;292(3):664-672. doi: 10.1148/radiol.2019182220. Epub 2019 Jul 2.

PMID:
31264950
8.

Annotation of gene product function from high-throughput studies using the Gene Ontology.

Attrill H, Gaudet P, Huntley RP, Lovering RC, Engel SR, Poux S, Van Auken KM, Georghiou G, Chibucos MC, Berardini TZ, Wood V, Drabkin H, Fey P, Garmiri P, Harris MA, Sawford T, Reiser L, Tauber R, Toro S; Gene Ontology Consortium.

Database (Oxford). 2019 Jan 1;2019. doi: 10.1093/database/baz007.

9.

Hemophagocytic lymphohistiocytosis secondary to pembrolizumab treatment with insufficient response to high-dose steroids.

Lorenz G, Schul L, Bachmann Q, Angermann S, Slotta-Huspenina J, Heemann U, Küchle C, Schmaderer C, Jäger M, Tauber R, Retz M, Moog P.

Rheumatology (Oxford). 2019 Jun 1;58(6):1106-1109. doi: 10.1093/rheumatology/key447. No abstract available.

PMID:
30668880
10.

Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer.

Heck MM, Tauber R, Schwaiger S, Retz M, D'Alessandria C, Maurer T, Gafita A, Wester HJ, Gschwend JE, Weber WA, Schwaiger M, Knorr K, Eiber M.

Eur Urol. 2019 Jun;75(6):920-926. doi: 10.1016/j.eururo.2018.11.016. Epub 2018 Nov 22.

PMID:
30473431
11.

Early Experience of Rechallenge 177Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer.

Gafita A, Rauscher I, Retz M, Knorr K, Heck M, Wester HJ, D'Alessandria C, Weber WA, Eiber M, Tauber R.

J Nucl Med. 2019 May;60(5):644-648. doi: 10.2967/jnumed.118.215715. Epub 2018 Nov 15.

PMID:
30442756
12.

ECO, the Evidence & Conclusion Ontology: community standard for evidence information.

Giglio M, Tauber R, Nadendla S, Munro J, Olley D, Ball S, Mitraka E, Schriml LM, Gaudet P, Hobbs ET, Erill I, Siegele DA, Hu JC, Mungall C, Chibucos MC.

Nucleic Acids Res. 2019 Jan 8;47(D1):D1186-D1194. doi: 10.1093/nar/gky1036.

13.

The effect of blood sampling and preanalytical processing on human N-glycome.

Dědová T, Grunow D, Kappert K, Flach D, Tauber R, Blanchard V.

PLoS One. 2018 Jul 11;13(7):e0200507. doi: 10.1371/journal.pone.0200507. eCollection 2018.

14.

Outcomes of transcatheter aortic valve implantation compared with surgical aortic valve replacement in geriatric patients with chronic kidney disease
.

Shavit L, Silberman S, Tauber R, Merin O, Bitran D, Fink D.

Clin Nephrol. 2018 Aug;90(2):87-93. doi: 10.5414/CN109363.

PMID:
29792393
15.

Modeling and Predicting Tumor Response in Radioligand Therapy.

Kletting P, Thieme A, Eberhardt N, Rinscheid A, D'Alessandria C, Allmann J, Wester HJ, Tauber R, Beer AJ, Glatting G, Eiber M.

J Nucl Med. 2019 Jan;60(1):65-70. doi: 10.2967/jnumed.118.210377. Epub 2018 May 10.

16.

Hyperkalemia in patients treated with endoradiotherapy combined with amino acid infusion is associated with severe metabolic acidosis.

Pfob CH, Eiber M, Luppa P, Maurer F, Maurer T, Tauber R, D'Alessandria C, Feuerecker B, Scheidhauer K, Ott A, Heemann U, Schwaiger M, Schmaderer C.

EJNMMI Res. 2018 Feb 27;8(1):17. doi: 10.1186/s13550-018-0370-z.

17.

The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides.

Begum NJ, Thieme A, Eberhardt N, Tauber R, D'Alessandria C, Beer AJ, Glatting G, Eiber M, Kletting P.

J Nucl Med. 2018 Jun;59(6):929-933. doi: 10.2967/jnumed.117.203505. Epub 2018 Feb 1.

18.

Neutrophil-Lymphocyte Ratio: Prognostic Impact in Heart Surgery. Early Outcomes and Late Survival.

Silberman S, Abu-Yunis U, Tauber R, Shavit L, Grenader T, Fink D, Bitran D, Merin O.

Ann Thorac Surg. 2018 Feb;105(2):581-586. doi: 10.1016/j.athoracsur.2017.07.033. Epub 2017 Nov 11.

PMID:
29132702
19.

Preoperative aldosterone receptor blockade and outcomes of cardiac surgery in patients with chronic kidney disease
.

Shavit L, Silberman S, Tauber R, Merin O, Bitran D, Fink D.

Clin Nephrol. 2018 Mar;89(3):187-195. doi: 10.5414/CN109236.

PMID:
29092740
20.

AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide.

Seitz AK, Thoene S, Bietenbeck A, Nawroth R, Tauber R, Thalgott M, Schmid S, Secci R, Retz M, Gschwend JE, Ruland J, Winter C, Heck MM.

Eur Urol. 2017 Nov;72(5):828-834. doi: 10.1016/j.eururo.2017.07.024. Epub 2017 Aug 14.

PMID:
28818355
21.

Werner Reutter: A Visionary Pioneer in Molecular Glycobiology.

Hinderlich S, Tauber R, Bertozzi CR, Hackenberger CPR.

Chembiochem. 2017 Jul 4;18(13):1141-1145. doi: 10.1002/cbic.201700277. Epub 2017 Jun 16.

PMID:
28621497
22.

[The role of immunooncology in the treatment of urothelial cancer].

Retz M, Tauber R, Horn T.

Aktuelle Urol. 2017 Aug;48(4):329-335. doi: 10.1055/s-0043-107041. Epub 2017 Jun 7. German.

PMID:
28591872
23.

Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumor Burden in Prostate Cancer Using 68Ga-PSMA PET/CT.

Bieth M, Krönke M, Tauber R, Dahlbender M, Retz M, Nekolla SG, Menze B, Maurer T, Eiber M, Schwaiger M.

J Nucl Med. 2017 Oct;58(10):1632-1637. doi: 10.2967/jnumed.116.189050. Epub 2017 May 25.

24.

Uniportal video-assisted thoracic surgery: the Middle East experience.

Abu Akar F, Gonzalez-Rivas D, Ismail M, Deeb M, Reichenshtein Y, Hadas-Halpern I, Tauber R, Fink D.

J Thorac Dis. 2017 Apr;9(4):871-877. doi: 10.21037/jtd.2016.11.89.

25.

Reducing Macro- and Microheterogeneity of N-Glycans Enables the Crystal Structure of the Lectin and EGF-Like Domains of Human L-Selectin To Be Solved at 1.9 Å Resolution.

Wedepohl S, Dernedde J, Vahedi-Faridi A, Tauber R, Saenger W, Bulut H.

Chembiochem. 2017 Jul 4;18(13):1338-1345. doi: 10.1002/cbic.201700220. Epub 2017 Jun 6.

PMID:
28489325
26.

The Cell-Surface N-Glycome of Human Embryonic Stem Cells and Differentiated Hepatic Cells thereof.

Montacir H, Freyer N, Knöspel F, Urbaniak T, Dedova T, Berger M, Damm G, Tauber R, Zeilinger K, Blanchard V.

Chembiochem. 2017 Jul 4;18(13):1234-1241. doi: 10.1002/cbic.201700001. Epub 2017 May 15.

PMID:
28370937
27.

High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection.

Poller W, Kaya Z, Muche M, Kasner M, Skurk C, Kappert K, Tauber R, Escher F, Schultheiss HP, Epple HJ, Landmesser U.

Clin Res Cardiol. 2017 Jul;106(7):551-556. doi: 10.1007/s00392-017-1086-1. Epub 2017 Feb 24.

PMID:
28236021
28.

The ascites N-glycome of epithelial ovarian cancer patients.

Biskup K, Braicu EI, Sehouli J, Tauber R, Blanchard V.

J Proteomics. 2017 Mar 22;157:33-39. doi: 10.1016/j.jprot.2017.02.001. Epub 2017 Feb 8.

PMID:
28188862
29.

[Bone-specific therapy with radium-223 dichloride : Castration-resistant prostate cancer with symptomatic bone metastases].

Tauber R, Gschwend J, Scheidhauer K, Eiber M, Krönke M.

Urologe A. 2017 Jan;56(1):24-31. doi: 10.1007/s00120-016-0300-5. German.

PMID:
28058455
30.

Untreated Mitral Regurgitation Does Not Affect Survival of Elderly Patients Undergoing TAVI.

Silberman S, Fink D, Butnaru A, Balkin J, Almagor Y, Tauber R, Merin O.

J Heart Valve Dis. 2016 Jan;25(1):46-50.

PMID:
27989083
31.

[PSMA-targeted radioligand therapy in prostate cancer].

Heck MM, Retz M, Tauber R, Knorr K, Kratochwil C, Eiber M.

Urologe A. 2017 Jan;56(1):32-39. doi: 10.1007/s00120-016-0274-3. Review. German.

PMID:
27885457
32.

Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions.

Okamoto S, Thieme A, Allmann J, D'Alessandria C, Maurer T, Retz M, Tauber R, Heck MM, Wester HJ, Tamaki N, Fendler WP, Herrmann K, Pfob CH, Scheidhauer K, Schwaiger M, Ziegler S, Eiber M.

J Nucl Med. 2017 Mar;58(3):445-450. doi: 10.2967/jnumed.116.178483. Epub 2016 Sep 22.

33.

Next-generation sequencing in patients with advanced cancer: are we ready for widespread clinical use? A single institute's experience.

Grenader T, Tauber R, Shavit L.

Anticancer Drugs. 2016 Oct;27(9):899-907. doi: 10.1097/CAD.0000000000000406.

PMID:
27384593
34.

Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer.

Pyka T, Okamoto S, Dahlbender M, Tauber R, Retz M, Heck M, Tamaki N, Schwaiger M, Maurer T, Eiber M.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2114-2121. Epub 2016 Jun 12.

PMID:
27290607
35.

Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy.

Heck MM, Thaler MA, Schmid SC, Seitz AK, Tauber R, Kübler H, Maurer T, Thalgott M, Hatzichristodoulou G, Höppner M, Nawroth R, Luppa PB, Gschwend JE, Retz M.

BJU Int. 2017 Jan;119(1):30-37. doi: 10.1111/bju.13493. Epub 2016 Apr 27.

36.

Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer.

Heck MM, Retz M, D'Alessandria C, Rauscher I, Scheidhauer K, Maurer T, Storz E, Janssen F, Schottelius M, Wester HJ, Gschwend JE, Schwaiger M, Tauber R, Eiber M.

J Urol. 2016 Aug;196(2):382-91. doi: 10.1016/j.juro.2016.02.2969. Epub 2016 Mar 8.

PMID:
26964917
37.

68Ga Prostate-Specific Membrane Antigen Uptake in Renal Cell Cancer Lymph Node Metastases.

Einspieler I, Tauber R, Maurer T, Schwaiger M, Eiber M.

Clin Nucl Med. 2016 May;41(5):e261-2. doi: 10.1097/RLU.0000000000001128.

PMID:
26859205
38.

Structural requirements of mono- and multivalent L-selectin blocking aptamers for enhanced receptor inhibition in vitro and in vivo.

Riese SB, Buscher K, Enders S, Kuehne C, Tauber R, Dernedde J.

Nanomedicine. 2016 May;12(4):901-908. doi: 10.1016/j.nano.2015.12.379. Epub 2016 Jan 7.

PMID:
26772426
39.

Acute-phase glycoprotein N-glycome of ovarian cancer patients analyzed by CE-LIF.

Weiz S, Wieczorek M, Schwedler C, Kaup M, Braicu EI, Sehouli J, Tauber R, Blanchard V.

Electrophoresis. 2016 Jun;37(11):1461-7. doi: 10.1002/elps.201500518. Epub 2016 Feb 17.

PMID:
26763099
40.

[Antegrade scrotal sclerosis therapy. Gold Standard of varicocele treatment].

Tauber R, Schmolling K, Ulm K.

Urologe A. 2015 Aug;54(8):1121-2. German. No abstract available.

PMID:
26465026
41.

[Does mitral valve annuloplasty improve long-term survival in patients having moderate ischemic mitral regurgitation undergoing CABG?].

Silberman S, Merin O, Fink D, Alshousha A, Shachar S, Tauber R, Butnaro A, Bitran D.

Harefuah. 2014 Dec;153(12):705-8, 754. Hebrew.

PMID:
25654909
42.

Cupulin is a zona pellucida-like domain protein and major component of the cupula from the inner ear.

Dernedde J, Weise C, Müller EC, Hagiwara A, Bachmann S, Suzuki M, Reutter W, Tauber R, Scherer H.

PLoS One. 2014 Nov 4;9(11):e111917. doi: 10.1371/journal.pone.0111917. eCollection 2014.

43.

Rapid analysis of cell surface N-glycosylation from living cells using mass spectrometry.

Hamouda H, Kaup M, Ullah M, Berger M, Sandig V, Tauber R, Blanchard V.

J Proteome Res. 2014 Dec 5;13(12):6144-51. doi: 10.1021/pr5003005. Epub 2014 Nov 13.

PMID:
25348702
44.

Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany.

Adler A, Geiger S, Keil A, Bias H, Schatz P, deVos T, Dhein J, Zimmermann M, Tauber R, Wiedenmann B.

BMC Gastroenterol. 2014 Oct 17;14:183. doi: 10.1186/1471-230X-14-183.

45.

Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.

Schwedler C, Kaup M, Weiz S, Hoppe M, Braicu EI, Sehouli J, Hoppe B, Tauber R, Berger M, Blanchard V.

Anal Bioanal Chem. 2014 Nov;406(28):7185-93. doi: 10.1007/s00216-014-8168-y. Epub 2014 Sep 19.

PMID:
25234305
46.

The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.

Biskup K, Braicu EI, Sehouli J, Tauber R, Blanchard V.

Dis Markers. 2014;2014:238197. doi: 10.1155/2014/238197. Epub 2014 Aug 12.

47.

Preoperative hemoglobin and outcomes in patients with CKD undergoing cardiac surgery.

Shavit L, Hitti S, Silberman S, Tauber R, Merin O, Lifschitz M, Slotki I, Bitran D, Fink D.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1536-44. doi: 10.2215/CJN.00110114. Epub 2014 Jul 3.

48.

Sialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobulin G N-glycans of ovarian cancer patients.

Schwedler C, Kaup M, Petzold D, Hoppe B, Braicu EI, Sehouli J, Ehlers M, Berger M, Tauber R, Blanchard V.

Electrophoresis. 2014 Apr;35(7):1025-31.

PMID:
24812685
49.

Enzalutamide after docetaxel and abiraterone therapy in metastatic castration-resistant prostate cancer.

Schmid SC, Geith A, Böker A, Tauber R, Seitz AK, Kuczyk M, von Klot C, Gschwend JE, Merseburger AS, Retz M.

Adv Ther. 2014 Feb;31(2):234-41. doi: 10.1007/s12325-014-0092-1. Epub 2014 Jan 18.

PMID:
24442834
50.

Comparison between transcatheter and surgical aortic valve replacement: a single-center experience.

Silberman S, Abu Akr F, Bitran D, Almagor Y, Balkin J, Tauber R, Merin O.

J Heart Valve Dis. 2013 Jul;22(4):448-54.

PMID:
24224405

Supplemental Content

Loading ...
Support Center